EULAR 2025 - Annual European Congress of Rheumatology

The EULAR 2025 - Annual European Congress of Rheumatology explores advancements in rheumatology, encompassing clinical, research, and public health topics to improve understanding, treatment, and management of rheumatic diseases.

Topics

• Clinical topics by disease
  • Rheumatoid arthritis - comorbidity and clinical aspects
  • Rheumatoid arthritis - prognosis, predictors and outcome
  • Rheumatoid arthritis - other biologic treatment
  • Rheumatoid arthritis - anti-TNF therapy
  • SLE, Sjögren`s and APS - treatment
  • Rheumatoid arthritis - non biologic treatment
  • Vasculitis
  • SLE, Sjögren`s and APS - clinical aspects (other than treatment)
  • Spondylarthropathies - treatment
  • Scleroderma, myositis and related syndromes
  • Psoriatic arthritis
  • Spondylarthropathies - clinical aspects (other than treatment)
  • Osteoporosis
  • Osteoarthritis
  • Infection-related rheumatic diseases
  • Crystal diseases, metabolic bone diseases other than osteoporosis
  • Back pain, mechanical musculoskeletal problems, local soft tissue disorders
  • Fibromyalgia
  • Paediatric rheumatology
  • Other orphan diseases
• Basic and translational research
  • Adaptive immunity (T cells and B cells) in rheumatic diseases
  • Genomics, genetic basis of disease and HLA/T cell recognition
  • Cytokines and inflammatory mediators
  • Innate immunity in rheumatic diseases
  • Rheumatoid arthritis - etiology, pathogenesis and animal models
  • Cartilage, synovium and osteoimmunology
  • SLE, Sjögren`s and APS - etiology, pathogenesis and animal models
  • Spondyloarthritis - etiology, pathogenesis and animal models
  • Basic science in paediatric rheumatology
  • Scleroderma, myosotis and related syndromes - etiology, pathogenesis and animal models
• Clinical topics by area of research
  • Public health, health services research, and health economics
  • Diagnostics and imaging procedures
  • Validation of outcome measures and biomarkers
  • Epidemiology, risk factors for disease or disease progression
  • Education
  • Rehabilitation

Who should Attend

Rheumatology professionals.